These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 15333681)
41. Consistent sequence variation of Epstein-Barr virus nuclear antigen 1 in primary tumor and peripheral blood cells of patients with nasopharyngeal carcinoma. Wang WY; Chien YC; Jan JS; Chueh CM; Lin JC Clin Cancer Res; 2002 Aug; 8(8):2586-90. PubMed ID: 12171888 [TBL] [Abstract][Full Text] [Related]
42. [Quantitative analysis of plasma Epstein-Barr virus (EBV) DNA for monitoring of recurrence and metastasis in nasopharyngeal carcinoma patients after radiotherapy]. Li YH; Shao JY; Zhao MQ; Gao HY; Li LR; Guan ZZ; Zeng YX Ai Zheng; 2003 Jun; 22(6):645-8. PubMed ID: 12948418 [TBL] [Abstract][Full Text] [Related]
43. Detection of cell free Epstein-Barr virus DNA in sera from patients with nasopharyngeal carcinoma. Hsiao JR; Jin YT; Tsai ST Cancer; 2002 Feb; 94(3):723-9. PubMed ID: 11857305 [TBL] [Abstract][Full Text] [Related]
44. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma. Tsai ST; Jin YT; Mann RB; Ambinder RF Cancer; 1998 Apr; 82(8):1449-53. PubMed ID: 9554519 [TBL] [Abstract][Full Text] [Related]
45. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma]. Cao SM; Min HQ; Gao JS; Hong MH; Xiao XB; Zhang CQ; Liu XD; Zhang AL; Guo X Ai Zheng; 2003 Mar; 22(3):302-6. PubMed ID: 12654192 [TBL] [Abstract][Full Text] [Related]
46. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area. Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688 [TBL] [Abstract][Full Text] [Related]
47. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma. Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452 [TBL] [Abstract][Full Text] [Related]
48. Plasma Epstein-Barr virus (EBV) DNA: role as a screening test for nasopharyngeal carcinoma (NPC)? Wong LP; Lai KT; Tsui E; Kwong KH; Tsang RH; Ma ES Int J Cancer; 2005 Nov; 117(3):515-6. PubMed ID: 15906350 [No Abstract] [Full Text] [Related]
49. Serum/plasma viral DNA: mechanisms and diagnostic applications to nasopharyngeal and cervical carcinoma. Mutirangura A Ann N Y Acad Sci; 2001 Sep; 945():59-67. PubMed ID: 11708495 [TBL] [Abstract][Full Text] [Related]
50. Combined determination of Epstein-Barr virus-related antibodies and antigens for diagnosis of nasopharyngeal carcinoma. Luo YL; Ou GP; Chi PD; Liang YN; Liu YH; Huang MY Ai Zheng; 2009 Jan; 28(1):76-8. PubMed ID: 19448423 [TBL] [Abstract][Full Text] [Related]
51. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Wong AM; Kong KL; Tsang JW; Kwong DL; Guan XY Cancer; 2012 Feb; 118(3):698-710. PubMed ID: 21720996 [TBL] [Abstract][Full Text] [Related]
52. Systematic review on Epstein-Barr virus (EBV) DNA in diagnosis of nasopharyngeal carcinoma in Asian populations. Han BL; Xu XY; Zhang CZ; Wu JJ; Han CF; Wang H; Wang X; Wang GS; Yang SJ; Xie Y Asian Pac J Cancer Prev; 2012; 13(6):2577-81. PubMed ID: 22938423 [TBL] [Abstract][Full Text] [Related]
53. Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma. Chan KC Chin J Cancer; 2014 Dec; 33(12):598-603. PubMed ID: 25418194 [TBL] [Abstract][Full Text] [Related]
54. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma]. Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265 [TBL] [Abstract][Full Text] [Related]
55. Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy. Vo JH; Nei WL; Hu M; Phyo WM; Wang F; Fong KW; Tan T; Soong YL; Cheah SL; Sommat K; Low H; Ling B; Ng J; Tan WL; Chan KS; Oon L; Ying JY; Tan MH Sci Rep; 2016 Dec; 6(1):13. PubMed ID: 28442757 [TBL] [Abstract][Full Text] [Related]
56. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. Young LS; Dawson CW; Clark D; Rupani H; Busson P; Tursz T; Johnson A; Rickinson AB J Gen Virol; 1988 May; 69 ( Pt 5)():1051-65. PubMed ID: 2836550 [TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr Virus EBNA-2 Polymorphic Patterns in Nasopharyngeal Carcinoma in Southern China. Wu G; Liu X; Liu S; Shu J; Sun Z; Luo B Intervirology; 2015; 58(6):386-92. PubMed ID: 27070148 [TBL] [Abstract][Full Text] [Related]
58. Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma. Chan KC; Lo YM Semin Cancer Biol; 2002 Dec; 12(6):489-96. PubMed ID: 12450734 [TBL] [Abstract][Full Text] [Related]
59. Detection of human papilloma virus and Epstein-Barr virus DNA in nasopharyngeal carcinoma by polymerase chain reaction. Tung YC; Lin KH; Chu PY; Hsu CC; Kuo WR Kaohsiung J Med Sci; 1999 May; 15(5):256-62. PubMed ID: 10375867 [TBL] [Abstract][Full Text] [Related]
60. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen. Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]